Literature DB >> 8112358

Serum bactericidal activity after administration of four cephalosporins in healthy volunteers.

S Lemmen1, A Kropec, I Engels, A Busse, F D Daschner.   

Abstract

Serum bactericidal activity (SBA) was determined against ten strains each of Staphylococcus aureus, Klebsiella pneumoniae, Proteus vulgaris and Enterobacter cloacae in six volunteers 1 h and 4 h after intravenous infusion of 1 g and 2 g cefotaxime and cefmenoxime, and 2 g flomoxef, and against ten strains of Pseudomonas aeruginosa after infusion of 1 g and 2 g ceftazidime. Flomoxef showed the highest SBA against methicillin-susceptible Staphylococcus aureus. All cephalosporins had high SBA against gram-negative rods. Cefotaxime had the highest SBA against Klebsiella pneumoniae and Enterobacter cloacae. The SBA against Pseudomonas aeruginosa after 1 g and 2 g doses of ceftazidime was very similar.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8112358     DOI: 10.1007/bf02000408

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  10 in total

1.  Evaluation of novel antipseudomonal drugs using the serum bactericidal activity test.

Authors:  I Braveny; K Machka; D Milatovic
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

2.  Crossover assessment of serum bactericidal activity and pharmacokinetics of five broad-spectrum cephalosporins in the elderly.

Authors:  R G Deeter; M P Weinstein; K A Swanson; J S Gross; L C Bailey
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 3.  Drug therapy. Serum bactericidal activity as a monitor of antibiotic therapy.

Authors:  J S Wolfson; M N Swartz
Journal:  N Engl J Med       Date:  1985-04-11       Impact factor: 91.245

4.  Comparison of antibiotic activities by using serum bactericidal activity over time.

Authors:  B J Guglielmo; L C Rodondi
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

5.  Bactericidal activity of ceftazidime in serum compared with that of ticarcillin combined with amikacin.

Authors:  H C Standiford; G L Drusano; B Fitzpatrick; B Tatem; S C Schimpff
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

6.  Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis.

Authors:  M P Weinstein; C W Stratton; H B Hawley; A Ackley; L B Reller
Journal:  Am J Med       Date:  1987-08       Impact factor: 4.965

Review 7.  Technical aspects and clinical correlations of the serum bactericidal test.

Authors:  H C Standiford; B A Tatem
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

8.  Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae.

Authors:  Y Van Laethem; H Lagast; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

9.  Assessment of serum bactericidal activity after administration of cefoperazone, cefotaxime, ceftizoxime, and moxalactam to healthy subjects.

Authors:  S L Barriere; D C Ozasa; J Mordenti
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

10.  High-pressure liquid chromatographic method for analysis of cephalosporins.

Authors:  S A Signs; T M File; J S Tan
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

  10 in total
  1 in total

Review 1.  Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections.

Authors:  R N Brogden; C M Spencer
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.